| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2013 | WO2013102897A1 Polymorphs of perampanel |
| 07/11/2013 | WO2013102860A1 Therapeutic use of imidazopyridine derivatives |
| 07/11/2013 | WO2013102826A1 N-aminosulfonyl benzamides |
| 07/11/2013 | WO2013102825A1 Cdcp1 and breast cancer |
| 07/11/2013 | WO2013102741A1 Delta-crystalline form of perindopril arginine salt, preparation method thereof, and pharmaceutical compositions containing same |
| 07/11/2013 | WO2013102665A1 Oromucosal liquid estradiol compositions |
| 07/11/2013 | WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 07/11/2013 | WO2013102651A1 Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide |
| 07/11/2013 | WO2013102626A1 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament |
| 07/11/2013 | WO2013102437A1 Uses of danshen or danshen preparation in preparation of drugs for treating diseases related to hepatic fibrosis |
| 07/11/2013 | WO2013102431A1 Therapeutically active compounds and their methods of use |
| 07/11/2013 | WO2013102249A1 N-phenylpiperazine derivatives that are antagonists of α1a, α1d adrenoceptors and 5-ht1a receptors for the treatment of benign prostate hyperplasia, pharmaceutical compositions containing the same |
| 07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use |
| 07/11/2013 | WO2013102234A1 Formulation and method for treatment of pain and/or inflammation associated with a skin condition |
| 07/11/2013 | WO2013087808A8 Pharmaceutical composition comprising a pyrazolopyrimidine and cyclodextrin |
| 07/11/2013 | WO2013074048A3 Tablet forms comprising quetiapine fumarate |
| 07/11/2013 | WO2013072762A3 Transdermal propranolol patch for treatment of malignant melanoma |
| 07/11/2013 | WO2013071056A3 Combination drug therapy for the treatment of solid tumors |
| 07/11/2013 | WO2013070981A3 Treating er stress related disorders by stabilizing intracellular calcium homeostasis |
| 07/11/2013 | WO2013068993A3 Tyrosine isomers as therapeutic agents |
| 07/11/2013 | WO2013068879A3 Infant formula with high sn-2 palmitate and oligofructose |
| 07/11/2013 | WO2013067105A3 Nicotinic receptor non-competitive modulators |
| 07/11/2013 | WO2013063679A9 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 07/11/2013 | WO2013059791A3 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders |
| 07/11/2013 | WO2013059582A3 Small molecule inhibitors of histone deacteylases |
| 07/11/2013 | WO2013057687A3 Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| 07/11/2013 | WO2013057554A3 Therapeutic combinations of netupitant and palonosetron |
| 07/11/2013 | WO2013052787A3 Membrane activated chelators and use in the prevention and treatment of parasitic infection |
| 07/11/2013 | WO2013052647A3 Formulations and uses of retinoic acid receptor selective agonists |
| 07/11/2013 | WO2013051904A9 Composition for preventing and treating vision deterioration and age-related macular degeneration through retinal repair using ginseng/red ginseng extracts and ginsenoside |
| 07/11/2013 | WO2013049352A3 Anti-viral compounds |
| 07/11/2013 | WO2013049149A3 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 07/11/2013 | WO2013044176A3 Methods and compositions for the treatment of ischemic stroke |
| 07/11/2013 | WO2013039785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 07/11/2013 | WO2013036031A3 Pharmaceutical composition including a microrna486 expression inhibitor as an active ingredient for preventing and treating neurological disorders |
| 07/11/2013 | WO2013030838A3 Dendrimer-lyotropic liquid crystal (llc) systems |
| 07/11/2013 | WO2013030669A4 Compositions comprising thymoquinone for the treatment of inflammatory diseases |
| 07/11/2013 | WO2013025564A3 Furfural production from biomass |
| 07/11/2013 | WO2013024358A3 Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors |
| 07/11/2013 | WO2013023084A3 Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells |
| 07/11/2013 | WO2013019079A3 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 07/11/2013 | WO2013016332A3 Composition and method for treating migraines |
| 07/11/2013 | WO2013013240A3 Macrocyclic compounds and related compositons and methods of use |
| 07/11/2013 | WO2012174379A3 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using |
| 07/11/2013 | WO2012164398A3 Modulation of the ubiquitin-proteasome system (ups) |
| 07/11/2013 | WO2012085523A3 Skin sanitizer compositions comprising alcohol based emulsion |
| 07/11/2013 | WO2012061045A3 Methods and compositions for preserving retinal ganglion cells |
| 07/11/2013 | WO2012012339A4 Glycosylated acetaminophen pro-drug analogs |
| 07/11/2013 | WO2005060437A3 Composition combinations and methods for treating, preventing, reversing and inhibiting pain |
| 07/11/2013 | US20130178801 Otic formulations, methods and devices |
| 07/11/2013 | US20130178787 Dry Compositions and Devices Containing Such Dry Compostions for Use in Photodynamic Therapy or Photodynamic Diagnosis |
| 07/11/2013 | US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/11/2013 | US20130178624 Quinazoline derivatives |
| 07/11/2013 | US20130178537 Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
| 07/11/2013 | US20130178536 Substituted cis- and trans-stilbenes as therapeutic agents |
| 07/11/2013 | US20130178534 N-Nonanoylvanillylamine as an agent for reducing the appetite, as an agent for imparting a feeling of fullness and as a mood enhancer, and corresponding substance mixtures, orally consumable products and methods |
| 07/11/2013 | US20130178531 Methods and compositions for the treatment of diverticulosis |
| 07/11/2013 | US20130178530 Nutritional Compensation For Western-Type Diet |
| 07/11/2013 | US20130178529 Ibuprofen compositions and methods of making same |
| 07/11/2013 | US20130178528 Omega-3 diglyceride emulsions |
| 07/11/2013 | US20130178527 Method for prevention or treatment of degenerative neurologial brain disorders |
| 07/11/2013 | US20130178525 Methods and compositions for reducing body fat and adipocytes |
| 07/11/2013 | US20130178524 Prostaglandin-containing product |
| 07/11/2013 | US20130178522 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 07/11/2013 | US20130178517 Methods And Compositions For Treatment Of Lipogenic Virus Related Conditions |
| 07/11/2013 | US20130178516 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
| 07/11/2013 | US20130178503 Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone |
| 07/11/2013 | US20130178498 Bicyclic heteroaryl inhibitors of pde4 |
| 07/11/2013 | US20130178496 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/11/2013 | US20130178495 Ibudilast for relieving negative effects of medication overuse headache |
| 07/11/2013 | US20130178493 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders |
| 07/11/2013 | US20130178487 Quinazoline derivatives for the treatment of cancer diseases |
| 07/11/2013 | US20130178486 Serine/threonine kinase inhibitors |
| 07/11/2013 | US20130178484 Treatment of gout and hyperuricemia |
| 07/11/2013 | US20130178482 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl) carbamimidoyl)pyrazine-2-carboxamide |
| 07/11/2013 | US20130178481 Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds |
| 07/11/2013 | US20130178479 Pharmaceutical combinations |
| 07/11/2013 | US20130178478 Pyridazine amide compounds |
| 07/11/2013 | US20130178477 Methods of treating diabetic neuropathy using benzenesulfonamides |
| 07/11/2013 | US20130178476 Methotrexate composition |
| 07/11/2013 | US20130178473 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 07/11/2013 | US20130178472 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/11/2013 | US20130178467 Highly concentrated stable meloxicam solutions |
| 07/11/2013 | US20130178466 Treatment of Microbial Infections |
| 07/11/2013 | US20130178465 Intranasal dexmedetomidine compositions and methods of use thereof |
| 07/11/2013 | US20130178464 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/11/2013 | US20130178460 Thienopyrimidine compounds |
| 07/11/2013 | US20130178454 Combination of testosterone and ornithine decarboxylase (odc) inhibitors |
| 07/11/2013 | US20130178453 Cannabinoid Agonists |
| 07/11/2013 | US20130178452 Pharmaceutical composition containing a tetrahydrofolic acid |
| 07/11/2013 | US20130178451 Method of treating and preventing secondary hyperparathyroidism |
| 07/11/2013 | US20130178450 Methods for increasing the production or activity of catalase |
| 07/11/2013 | US20130178448 Treatment of Respiratory Disorders |
| 07/11/2013 | US20130178446 Method for decreasing sebum production |
| 07/11/2013 | US20130178445 Novel Benzopyran Compounds, Compositions and Uses Thereof |
| 07/11/2013 | US20130178443 Phenylquinazoline derivatives |
| 07/11/2013 | US20130178441 Methods for Extending Progression-Free Survival using 10-Propargyl-10-Deazaaminopterin |
| 07/11/2013 | US20130178440 Compositions and methods for treating skin cancer associated diseases |
| 07/11/2013 | US20130178439 Methods of treating an inflammatory-related disease |
| 07/11/2013 | US20130178436 Composition for preventing, improving, or treating renal disease including maillard browning reaction products of panax species plant extract |